On September 22, 2026, Clover Health Investments appointed former U.S. Senator Robert G. Torricelli as a Class I director and Dr. Brian J. Miller as a Class III director to fill previously disclosed vacancies, bringing the Board size to nine members. Torricelli joins the Audit Committee while Miller serves on the Clinical Committee. Each appointee receives a pro-rated annual retainer and an RSU award valued at $200,000 for 2026 service. The company operates in the healthcare technology sector, providing physician enablement software and Medicare Advantage insurance plans.
